Seretide 125 / 25 Mcg 120 Doses Evohaler

Seretide 125 / 25 mcg 120 Doses Evohaler

Description:

Seretide 125 / 25 mcg 120 Doses Evohaler is a prescription inhaled medicine used for the long-term control and prevention of asthma symptoms. It combines an inhaled corticosteroid (fluticasone propionate) and a long-acting beta2-agonist bronchodilator (salmeterol) in a single metered-dose inhaler (MDI). This combination helps reduce airway inflammation and keeps the airways open, improving breathing and helping to prevent asthma attacks when used regularly as maintenance therapy. It is not a rescue inhaler for sudden asthma symptoms and must be used exactly as prescribed by a healthcare professional.

Indications:

• Long-term maintenance treatment of asthma in adults and adolescents who require both an inhaled corticosteroid and a long-acting beta2-agonist.
• Prevention of asthma symptoms such as wheezing, shortness of breath, chest tightness, and cough.
• Reduction in the frequency and severity of asthma exacerbations when used regularly as controller therapy.
• Not indicated for the relief of acute bronchospasm or sudden asthma attacks (a separate fast-acting reliever inhaler is required for acute symptoms).

Active Ingredients / Key Components:

• Fluticasone propionate – 125 mcg per actuation (inhalation) (inhaled corticosteroid with anti-inflammatory action in the airways).
• Salmeterol (as salmeterol xinafoate) – 25 mcg per actuation (long-acting beta2-adrenergic agonist bronchodilator).
• Each Evohaler contains 120 metered doses (actuations).
• Other ingredients (excipients and propellants) are present but detailed composition and concentrations , please check the product leaflet or the manufacturer’s official website.

Dosage & Administration / How to Use:

• Use only as prescribed by your doctor. Do not change the dose or frequency without medical advice.
• Typical adult and adolescent dosing (example regimen – your doctor’s instructions may differ): usually 2 inhalations twice daily (morning and evening). Exact dose and frequency must be confirmed by the prescribing physician.
• For inhalation use only via the Seretide Evohaler device. Do not swallow.
• Shake the inhaler well before each use.
• How to use:
  • Remove the mouthpiece cover and check that the mouthpiece is clean and free from dust or foreign objects.
  • Shake the inhaler well.
  • Breathe out gently and fully, away from the inhaler.
  • Place the mouthpiece between your teeth and close your lips around it, without biting.
  • Start to breathe in slowly and deeply through your mouth, and at the same time press down on the canister to release one dose.
  • Continue to breathe in steadily and deeply, then remove the inhaler from your mouth and hold your breath for about 10 seconds or as long as comfortable.
  • Breathe out slowly.
• If a second inhalation is prescribed, wait about 30 seconds, then repeat the steps.
• Rinse your mouth with water and spit it out after each dose to help reduce the risk of oral thrush and hoarseness.
• Use every day, even if you feel well, to maintain control of asthma. Do not stop suddenly without consulting your doctor.
• This medicine is not for sudden asthma attacks. Always keep a fast-acting reliever (rescue) inhaler available for acute symptoms.

Clinical Benefits:

• Provides dual action asthma control by combining an anti-inflammatory corticosteroid (fluticasone) with a long-acting bronchodilator (salmeterol).
• Helps reduce chronic airway inflammation, decreasing sensitivity to asthma triggers over time.
• Maintains long-lasting bronchodilation, keeping airways open and improving lung function and breathing comfort.
• Reduces the frequency and severity of asthma exacerbations when used regularly as maintenance therapy.
• Improves day-to-day symptom control, helping to reduce wheezing, chest tightness, and night-time awakenings due to asthma.
• Convenient combination inhaler may improve adherence compared to using separate inhaled corticosteroid and bronchodilator products.

Warnings & Contraindications:

• For maintenance treatment only – not suitable for relief of acute asthma attacks or sudden shortness of breath. Use a short-acting bronchodilator (rescue inhaler) for acute symptoms.
• Do not use if you are allergic (hypersensitive) to fluticasone, salmeterol, or any of the other ingredients of the product.
• Use with caution in patients with cardiovascular disease (e.g., coronary artery disease, arrhythmias, hypertension), hyperthyroidism, diabetes mellitus, or seizure disorders.
• Long-term use of inhaled corticosteroids at high doses may be associated with systemic effects such as adrenal suppression, decreased bone mineral density, cataracts, or glaucoma; regular monitoring may be required in long-term therapy.
• May increase susceptibility to infections, including respiratory infections and oral candidiasis (thrush). Rinse mouth after use to reduce risk.
• Use with caution in patients with active or latent pulmonary tuberculosis or untreated fungal, bacterial, or viral infections of the respiratory tract.
• Do not abruptly discontinue without medical supervision, especially in patients on long-term high-dose inhaled corticosteroids.
• Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding. The doctor will weigh potential benefits and risks.
• Inform your doctor about all other medicines you are taking, especially other inhalers, beta-blockers, antifungals (e.g., ketoconazole), antivirals, or strong CYP3A4 inhibitors, as interactions may occur.
• Not intended to diagnose, treat, cure, or prevent any disease without medical supervision. Use only on prescription.
• Keep out of reach of children.

Side Effects:

• Common side effects may include headache, throat irritation, hoarseness, cough, and oral thrush (white patches in the mouth or throat).
• Other possible side effects: palpitations, mild tremor, muscle cramps, sinusitis, respiratory infections, and dry mouth.
• Inhaled corticosteroids may rarely cause systemic effects such as adrenal suppression, growth retardation in children and adolescents, decreased bone mineral density, cataracts, or glaucoma, especially with prolonged high-dose use.
• Serious allergic reactions (rash, itching, swelling of face/lips/tongue, severe dizziness, difficulty breathing) are rare but require immediate medical attention.
• Paradoxical bronchospasm (sudden worsening of wheezing or shortness of breath immediately after inhalation) may occur rarely; if this happens, stop using the inhaler and seek urgent medical help.
• If you experience chest pain, severe palpitations, vision changes, or worsening breathing, contact your doctor or seek emergency care immediately.

Storage Instructions:

Store in a cool, dry place away from direct sunlight and heat sources. Do not expose to temperatures above those stated in the package insert (exact temperature range not available in the provided information). Do not puncture, break, or burn the pressurized canister, even when it appears empty. Keep the mouthpiece clean and replace the mouthpiece cover after each use. Keep container tightly closed and keep out of reach of children.

Specifications:

• Product type: Inhaled prescription asthma controller medicine (metered-dose inhaler).
• Strength: 125 mcg fluticasone propionate + 25 mcg salmeterol per actuation.
• Total content: 120 metered doses (actuations) per Evohaler.
• Route of administration: Inhalation via mouth using the Evohaler device.
• Suitable for: Adults and adolescents as prescribed by a healthcare professional (exact age range per local prescribing information).

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.